Selective depletion of cancer cells with extrachromosomal DNA via lentiviral infection
Eunhee S. YiiD, Amit D. GujariD, Dacheng ZhaoiD, Kentaro SuinaiD, Xue JiniD, Katharina PardoniD, Qinghao YuiD, Larisa KagermazovaiD, Emmanuel Ekow KorsahiD, Noah A. DusseauiD, Jef D. BoekeiD, Anton George HensseniD, Roel G.W. VerhaakiD
Abstract
Dear Editor Extrachromosomal DNA (ecDNA), a major focal oncogene amplification mode found across cancer, has recently regained attention as an emerging cancer hallmark1,2, with a pervasive presence across cancers3,4. With technical advancements such as high-coverage sequencing and live-cell genome imaging, we can now investigate ecDNAs behaviors and functions 5-7. However, we still lack an understanding of how to eliminate ecDNA. We observed depletion of cells containing ecDNA during lentiviral but not transposon-based transduction while we sought to investigate the mechanism of ecDNA behavior. This discovery may provide critical information on utilizing a lentiviral system in emerging ecDNA research. Additionally, this observation suggests specific sensitivities for cells with ecDNA.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.59
- Field percentile
- top 35%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Extrachromosomal DNA is associated with decreased immune cell infiltration and antigen presentation, represents a potential cancer immune evasion mechanism
- Selective degradation of oncogenic extrachromosomal DNA by type I-E CRISPR
Ensieh M. Poursani, Vu Pham, … Orazio Vittorio·bioRxiv·Sep 21, 2025
- Rampant transcription replication conflict creates therapeutic vulnerability in extrachromosomal DNA containing cancers
Jun Tang, Natasha E. Weiser, … Howard Y. Chang·NaturePeer-reviewed·Nov 6, 2024
- Vitamin D promotes DNase1L3 to degrade ecDNA and inhibit the malignant progression of hepatocellular carcinoma
- Transcriptional immune suppression and upregulation of double stranded DNA damage and repair repertoires in ecDNA-containing tumors
- Pan-cancer characterization and clinical outcome of ecDNA-enhancer mediated transcriptional dysregulation
Tengwei Zhong, Huan Zhao, … Zhiyun Guo·bioRxiv·Sep 6, 2023